ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,040.53
      -0.50%
      US Tech 100
      20,778.00
      -0.69%
      Dow Jones
      44,544.66
      -0.75%
      Brent Oil
      76.385
      0.00%
      Bitcoin
      101,781.86
      -0.62%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Lifecore Biomedical Inc (LFCR) Quote

      Lifecore Biomedical Inc

      Lifecore Biomedical Inc (LFCR)

      NASDAQ
      5.94
      -0.16
      (-2.62%)
      Closed February 01 4:00PM
      Delayed by 15 minutes
      5.93
      -0.01
      (-0.17%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      5.94
      Bid
      5.60
      Ask
      10.96
      Volume
      145,630
      5.87 Day's Range 6.11
      3.6793 52 Week Range 8.90
      Market Cap
      219.93M
      Previous Close
      6.10
      Open
      6.07
      Last Trade
      1454
      @
      5.94
      (priorref)
      Last Trade Time
      Financial Volume
      $ 868,031
      VWAP
      5.9605
      Average Volume (3m)
      268,046
      Shares Outstanding
      37,025,331
      Dividend Yield
      -
      PE Ratio
      27.00
      Earnings Per Share (EPS)
      0.32
      Revenue
      128.26M
      Net Profit
      12.01M

      About Lifecore Biomedical Inc

      Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hy... Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Show more

      Sector
      Plastics,resins,elastomers
      Industry
      Plastics,resins,elastomers
      Website
      www.lifecore.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Lifecore Biomedical Inc is listed in the Plastics,resins,elastomers sector of the NASDAQ with ticker LFCR. The last closing price for Lifecore Biomedical was $6.10. Over the last year, Lifecore Biomedical shares have traded in a share price range of $ 3.6793 to $ 8.90.

      Lifecore Biomedical currently has 37,025,331 shares outstanding. The market capitalization of Lifecore Biomedical is $225.85 million. Lifecore Biomedical has a price to earnings ratio (PE ratio) of 27.00.

      Ask ADVFN Intelligence (AI)

      LFCR Latest News

      More News

      Form PRE 14A - Other preliminary proxy statements

      January 21 2025
      Edgar (US Regulatory)

      Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

      January 17 2025
      Edgar (US Regulatory)

      Form 8-K - Current report

      January 17 2025
      Edgar (US Regulatory)

      Lifecore Biomedical Announces Special Stockholder Meeting

      CHASKA, Minn., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...

      January 17 2025
      GlobeNewswire Inc.

      Form 8-K - Current report

      January 07 2025
      Edgar (US Regulatory)

      Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million

      Company Believes it is Well Positioned for Mid-Term and Long-Term Growth asCurrent Capacity Continues to Support up to $300 Million in Annual Revenue CHASKA, Minn., Jan. 07, 2025 (GLOBE...

      January 07 2025
      GlobeNewswire Inc.

      Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference

      CHASKA, Minn., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...

      January 06 2025
      GlobeNewswire Inc.

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      January 02 2025
      Edgar (US Regulatory)

      Form 8-K - Current report

      January 02 2025
      Edgar (US Regulatory)

      Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update

      -- Recorded Revenues of $32.6 Million for Q2 Fiscal 2025 -- -- Signed Multiple Development Agreements with New Customers -- -- Strengthened Balance Sheet with Financing Raising Approximately...

      January 02 2025
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.16-2.622950819676.16.45.7951801726.08763089CS
      4-1.15-16.22002820877.097.695.652897176.40958023CS
      12-0.5-7.763975155286.447.995.652680466.9244902CS
      26-0.46-7.18756.47.993.67932413445.90984867CS
      52-0.77-11.47540983616.718.93.67932162975.90874227CS
      156-3.14-34.58149779749.0811.4551.523198635.90932653CS
      260-3.14-34.58149779749.0811.4551.523198635.90932653CS

      LFCR - Frequently Asked Questions (FAQ)

      What is the current Lifecore Biomedical share price?
      The current share price of Lifecore Biomedical is $ 5.94
      How many Lifecore Biomedical shares are in issue?
      Lifecore Biomedical has 37,025,331 shares in issue
      What is the market cap of Lifecore Biomedical?
      The market capitalisation of Lifecore Biomedical is USD 225.85M
      What is the 1 year trading range for Lifecore Biomedical share price?
      Lifecore Biomedical has traded in the range of $ 3.6793 to $ 8.90 during the past year
      What is the PE ratio of Lifecore Biomedical?
      The price to earnings ratio of Lifecore Biomedical is 27
      What is the cash to sales ratio of Lifecore Biomedical?
      The cash to sales ratio of Lifecore Biomedical is 2.53
      What is the reporting currency for Lifecore Biomedical?
      Lifecore Biomedical reports financial results in USD
      What is the latest annual turnover for Lifecore Biomedical?
      The latest annual turnover of Lifecore Biomedical is USD 128.26M
      What is the latest annual profit for Lifecore Biomedical?
      The latest annual profit of Lifecore Biomedical is USD 12.01M
      What is the registered address of Lifecore Biomedical?
      The registered address for Lifecore Biomedical is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
      What is the Lifecore Biomedical website address?
      The website address for Lifecore Biomedical is www.lifecore.com
      Which industry sector does Lifecore Biomedical operate in?
      Lifecore Biomedical operates in the PLASTICS,RESINS,ELASTOMERS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      TCTMTCTM Kids IT Education Inc
      $ 0.764
      (321.87%)
      		729.72M
      REBNReborn Coffee Inc
      $ 3.31
      (63.05%)
      		55.54M
      FCUVFocus Universal Inc
      $ 5.87
      (56.62%)
      		1.73M
      SOPASociety Pass Inc
      $ 1.54
      (56.50%)
      		13.82M
      CYCNCyclerion Therapeutics Inc
      $ 3.92
      (54.33%)
      		82.39M
      ENVBEnveric Biosciences Inc
      $ 2.0899
      (-46.41%)
      		1.57M
      NIVFNewGenIvf Group Ltd
      $ 0.1489
      (-42.51%)
      		14.8M
      GLSTGlobal Star Acquisition Inc
      $ 8.83
      (-39.10%)
      		23.89k
      PRPHProPhase Labs Inc
      $ 0.2633
      (-38.02%)
      		872.46k
      SPGCSacks Parente Golf Inc
      $ 0.5601
      (-37.86%)
      		7.27M
      TCTMTCTM Kids IT Education Inc
      $ 0.764
      (321.87%)
      		729.72M
      NVDANVIDIA Corporation
      $ 120.07
      (-3.67%)
      		388.54M
      RIMEAlgorhythm Holdings Inc
      $ 0.02565
      (5.12%)
      		338.75M
      BHATBlue Hat Interactive Entertainment Technology
      $ 0.0355
      (-11.25%)
      		236.29M
      CLEUChina Liberal Education Holdings Ltd
      $ 0.1938
      (30.77%)
      		234.8M

      Discussion

      View Full Feed
      Seminole Red Seminole Red 5 minutes ago
      Prolific Anti-Trump FBI Agent’ Broke Protocol To Spearhead Election Lawfare: Whistleblower

      https://thefederalist.com/2025/01/31/prolific-anti-trump-fbi-agent-broke-protocol-to-spearhead-election-lawfare-whistleblower/?fbclid=IwY2xjawIKzw1leHRuA2FlbQIxMQABHTUyKpt_EgsBaY_8CIA322h6bvZNMc
      weedtrader420 weedtrader420 11 minutes ago
      That’s a shame you couldn’t buy it in Canada, When I told you when it was under $.50
      PLBY
      pgsd pgsd 13 minutes ago
      The great vaccine 'race' is on with $nwbo being well placed for rapid development as we await to start our journey on approvals and commercialization.

      Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research :
      27 Jan 2025

      Glo
      NWBO
      wagner wagner 14 minutes ago
      https://www.usgs.gov/news/national-news-release/usgs-value-us-mineral-production-edged-2024

      NioCorp mentioned on Lists 

      🤗💯🤗
      NB
      eagle8 eagle8 15 minutes ago
      dstock,

      Perhaps after this ruling by Judge Stein, a number of repentants will come forward as whistleblowers.
      Now they are safer in their choice because they too know that discovery is underway.

      GLTU
      NWBO
      andebais andebais 16 minutes ago
      Wow. Lots of moving parts here.Looks like we keep the Winner!
      From X

      BC shareholders: Summarizing the latest info. BC & Medesol Global have parted ways. Both companies can now manufacture and sell all Medesol product recipes globally (BC seperately has their other IP blends) M
      MGON
      edbi46 edbi46 16 minutes ago
      No WORD SALADS, no SUBSTANTIAL/NONE SUBSTANTIAL ACCUSATIONS, ( for like 13 years, from Oct. 2011 and counting?? ), did/will do any desired effect !!!!! We know they are watching BASHING work here, before the checks are being cut!!!


      ---------------------------------------------
      BMI LMT MCF
      pgsd pgsd 27 minutes ago
      Experts Forecast Cancer Research and Treatment Advances in 2025 :
      January 10, 2025

      Advances in Immunotherapy in 2025 :

      "He said that there has already been early proof of concept that vaccines may help the immune system fight cancers that typically harbor very fe
      NWBO
      doinit doinit 30 minutes ago
      a new addition to sales potential,, In 2022, Mitsubishi reached an agreement with Alaska Gasline Development Corporation (AGDC), the state-owned company overseeing the LNG proposal, to assess the feasibility of producing ammonia there. Mitsubishi has not committed to the project beyond an assessment
      PTHRF
      max mastiff max mastiff 40 minutes ago
      Morning Drug Doctor I was wondering if you are in the HMBL stock that’s supposed to be merging if you are what are your thoughts on it
      HMBL
      nowwhat2 nowwhat2 40 minutes ago
      System Maint THIS Wknd ?........Yikes



      https://investorshub.advfn.com/uimage/uploads/2025/2/1/cbbliBTC_@_1_15D_GLITCH_HELP_MAG_100K.jpg

      Last 101,888





      Jan 16
      https://investorshub.advfn.com/uimage/uplo
      doinit doinit 41 minutes ago
      Japan pledge to finance LNG pipeline in AK... https://www.oilandgas360.com/exclusive-japan-weighs-alaska-lng-pipeline-pledge-to-win-trumps-favour/#utm_source=rss&utm_medium=rss&utm_campaign=exclusive-japan-weighs-alaska-lng-pipeline-pledge-to-win-trumps-favour
      PTHRF
      trader53 trader53 41 minutes ago
      DPLS - "Short Squeeze" Explained


      I'll Alert you of stocks to Buy,
      before the Run happens !

      https://investorshub.advfn.com/uicon/155361.png?cb=636946062923800000

      ________________________________________________


      DPLS
      trader53 trader53 43 minutes ago
      DPLS - "Short Squeeze" Explained


      I'll Alert you of stocks to Buy,
      before the Run happens !

      https://investorshub.advfn.com/uicon/155361.png?cb=636946062923800000

      ________________________________________________


      DPLS
      bbotcs bbotcs 43 minutes ago
      lj: This type of journalism can start a panic in the market: https://www.dailymail.co.uk/news/article-14348965/Hedge-funds-massive-bet-stock-market-crash-raises-alarm.html
      nowwhat2 nowwhat2 46 minutes ago
      Oh-oh

      https://investorshub.advfn.com/uimage/uploads/2025/2/1/cbbliBTC_@_1_15D_GLITCH_HELP_MAG_100K.jpg


      Last 101,888





      Spidey senses.......

      Jumbo glitch
      BTCUSD
      pgsd pgsd 48 minutes ago
      MSD (Merck) Ireland announces acquisition of WuXi Vaccines’ Dundalk site

      MSD's acquisition of the WuXi Vaccines Dundalk site strengthens the company’s long-standing commitment to Ireland, bringing its footprint to eight locations nationwide with over 3,000 currently employed across th
      NWBO
      threewheeler threewheeler 59 minutes ago
      KRTLBIOTECH OTC:KRTL
      @KRTLBiotech
      Attention $KRTL shareholders: Management is scheduling one of several press releases for the beginning of next week.
      8:45 PM · Jan 31, 2025
      ·
      341
      Views
      KRTL
      threewheeler threewheeler 59 minutes ago
      KRTLBIOTECH OTC:KRTL
      @KRTLBiotech
      Attention $KRTL shareholders: Management is scheduling one of several press releases for the beginning of next week.
      8:45 PM · Jan 31, 2025
      ·
      341
      Views
      KRTL
      threewheeler threewheeler 59 minutes ago
      KRTLBIOTECH OTC:KRTL
      @KRTLBiotech
      Attention $KRTL shareholders: Management is scheduling one of several press releases for the beginning of next week.
      8:45 PM · Jan 31, 2025
      ·
      341
      Views
      KRTL
      Drugdoctor Drugdoctor 1 hour ago
      Well, once a company takes over a shell, and changes the name to their new company, previous owners will quickly be forgotten. It's up to the new company to do their own image building. I think there was more than the problem with the holligans at play here.
      GVSI
      Looking4aprofit Looking4aprofit 1 hour ago
      Further to the post, I asked Gemini about this ruling and Discovery :

      Yes, this ruling will likely lead to discovery, at least regarding the claims that survived the motion to dismiss.

      Here's why:

      Motion to Dismiss Stage: The document you provided is rela
      NWBO
      dhyan40 dhyan40 1 hour ago
      The Silver Suppression and Systemic Risk
      Silver continues to be a key industrial and monetary asset. The current gold-to-silver ratio stands at 88:1 - significantly above historical norms of 16:1 - prompting discussions around price alignment. With a four-year supply deficit and increasing in
      LEHNQ
      nowwhat2 nowwhat2 1 hour ago
      I so showed you this was coming....
      https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175568712

      https://investorshub.advfn.com/uimage/uploads/2025/2/1/ijevsplby_121212_17_w__cup__girl.jpg

      That was on December 16th
      Jan 31 NEWS https://www.mark
      PLBY
      Seminole Red Seminole Red 1 hour ago
      Amy Klobuchar Attempts To Set A Trap For Kash Patel. It Does Not Go Well.

      Patel asked Committee Chair Sen. Chuck Grassley (R-IA) for extra time, after which Klobuchar interrupted and repeatedly demanded that Patel answer her question.

      Instead, Patel was given a moment t

      Your Recent History

      NASDAQ
      LFCR
      Lifecore Biomedical
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads